Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| KDM4B promotes acute myeloid leukemia associated with AML1-ETO by regulating chromatin accessibility. | FASEB Bioadv | 2021 | 34938963 | PubTator, text mining | PubMed |
| The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer. | Nat Commun | 2021 | 34934057 | PubTator, text mining | PubMed |
| Epigenetic silencing of UBXN8 contributes to leukemogenesis in t(8;21) acute myeloid leukemia. | Exp Mol Med | 2021 | 34921223 | PubTator, text mining | PubMed |
| Gene-specific quantification of nascent transcription following targeted degradation of endogenous proteins in cultured cells. | STAR Protoc | 2021 | 34917979 | PubTator, text mining | PubMed |
| Podocalyxin promotes an impermeable epithelium and inhibits pro-implantation factors to negatively regulate endometrial receptivity. | Sci Rep | 2021 | 34907278 | PubTator, text mining | PubMed |
| First report from a single center retrospective study in Kazakhstan on acute myeloid leukemia treatment outcomes. | Sci Rep | 2021 | 34907276 | PubTator, text mining | PubMed |
| miRNA-144 targeting DNAJC3-AS1 reverses the resistance of the breast cancer cell line Michigan Cancer Foundation-7 to doxorubicin. | Bioengineered | 2021 | 34895046 | PubTator, text mining | PubMed |
| High Expression of VAV Gene Family Predicts Poor Prognosis of Acute Myeloid Leukemia. | Technol Cancer Res Treat | 2021 | 34894858 | PubTator, text mining | PubMed |
| The Role of Long Non-Coding RNAs (lncRNAs) in Female Oriented Cancers. | Cancers (Basel) | 2021 | 34885213 | PubTator, text mining | PubMed |
| Dynamic assessment of measurable residual disease in favorable-risk acute myeloid leukemia in first remission, treatment, and outcomes. | Blood Cancer J | 2021 | 34873148 | PubTator, text mining | PubMed |
| Deconvolution of Bulk Gene Expression Profiles with Single-Cell Transcriptomics to Develop a Cell Type Composition-Based Prognostic Model for Acute Myeloid Leukemia. | Front Cell Dev Biol | 2021 | 34869351 | PubTator, text mining | PubMed |
| Evaluation of the Mutation Profile via Next-Generation Sequencing in a Turkish Population With Non-small Cell Lung Cancer. | Balkan Med J | 2021 | 34860166 | PubTator, text mining | PubMed |
| Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia. | Front Oncol | 2021 | 34858828 | PubTator, text mining | PubMed |
| Cancer stem cells: advances in biology and clinical translation-a Keystone Symposia report. | Ann N Y Acad Sci | 2021 | 34850398 | PubTator, text mining | PubMed |
| Use of gemtuzumab ozogamicin in relapsed refractory acute myeloid leukemia: Multi-center real life data from Turkey. | Leuk Res Rep | 2021 | 34849337 | PubTator, text mining | PubMed |
| Small but Mighty-The Emerging Role of snoRNAs in Hematological Malignancies. | Noncoding RNA | 2021 | 34842767 | PubTator, text mining | PubMed |
| Human Brown Adipose Tissue and Metabolic Health: Potential for Therapeutic Avenues. | Cells | 2021 | 34831253 | PubTator, text mining | PubMed |
| A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia. | Cells | 2021 | 34831055 | PubTator, text mining | PubMed |
| Single-Cell Sequencing: Biological Insight and Potential Clinical Implications in Pediatric Leukemia. | Cancers (Basel) | 2021 | 34830811 | PubTator, text mining | PubMed |
| The long non-coding RNA CDK6-AS1 overexpression impacts on acute myeloid leukemia differentiation and mitochondrial dynamics. | iScience | 2021 | 34816103 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=48